Top

Reactions Weekly

Published in:

01-12-2023 | Haloperidol | Case report

Haloperidol/unspecified antipsychotics

Hyperprolactinaemia and pituitary macroprolactinoma

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Bazhenov A, et al. Dopamine Challenge: Treatment Of Pituitary Macroadenoma/Prolactinoma In Patient On Antipsychotic Medication. Journal of the Endocrine Society 7 (Suppl. 1): A722 abstr. SAT620, Oct 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.1353 [abstract]

Title: Haloperidol/unspecified antipsychotics
Hyperprolactinaemia and pituitary macroprolactinoma
Publication date: 01-12-2023
Publisher: Springer International Publishing
Keywords: Haloperidol
Antipsychotics
Antipsychotics
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-51012-1

At a glance: The STEP trials

Springer Medicine

Haloperidol/unspecified antipsychotics

Hyperprolactinaemia and pituitary macroprolactinoma

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Etomidate/Hydrocortisone/Ketoconazole

Bleomycin/cisplatin/etoposide

COVID-19-vaccine

Pembrolizumab

Isotretinoin

Pembrolizumab